Press Releases
  • SOLUS V2 Blood Glucose Management System
  • SOLUS V2 device
  • Alkafizz Granules
  • Gelacid Chewable Tablets / Suspension
  • Betavit AFR capsules
  • Relicalm tablets

Cipla Wins ‘Best Company in Emerging Market’ Award.

Monday, January 29, 2007

Cipla Medpro is proud to announce that Cipla Ltd, their partner in the SADC countries of Africa, won the prestigious "Best Company in an Emerging Market" Award at the International Scrip Awards in London in November 2006. This award is bestowed on a company that shows excellent performance across their business, from growing sales and profits to new product launches. The award is judged across the markets of Asia, Central and Eastern Europe, Central and South America, the Middle East and Africa.
On receiving the prestigious award Mr. Amar Lulla, CEO of Cipla said: "We are delighted and honoured on being bestowed the Scrip Best Company in an Emerging Market Award. The award pays testament to the tremendous team effort of all Ciplaites who share their joy on receiving this honour".
Cipla Medpro would like to congratulate our partner on this impressive award. During our decade-long partnership we have experienced first hand Cipla Ltd's dedication to the pharmaceutical industry and their ongoing mission to make top quality medication accessible and affordable to all people.